GE HealthCare Technologies Inc.
$ 63.07
-4.00%
17 Jul - close price
- Market Cap 28,690,024,000 USD
- Current Price $ 63.07
- High / Low $ 66.28 / 62.64
- Stock P/E 15.77
- Book Value 23.45
- EPS 4.00
- Next Earning Report 2026-07-29
- Dividend Per Share $0.14
- Dividend Yield 0.21 %
- Next Dividend Date 2026-08-14
- ROA 0.05 %
- ROE 0.20 %
- 52 Week High 89.69
- 52 Week Low 58.75
About
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
Analyst Target Price
$79.44
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-29 | 2026-02-04 | 2025-10-29 | 2025-07-30 | 2025-04-30 | 2025-02-13 | 2024-10-30 | 2024-07-31 | 2024-04-30 | 2024-02-06 | 2023-10-31 | 2023-07-25 |
| Reported EPS | 0.99 | 1.44 | 0.98 | 1.06 | 1.01 | 1.57 | 1.14 | 1 | 0.9 | 1.18 | 0.99 | 0.92 |
| Estimated EPS | 1.05 | 1.4 | 1 | 0.92 | 0.91 | 1.26 | 1.05 | 0.98 | 0.91 | 1.07 | 0.9 | 0.87 |
| Surprise | -0.06 | 0.04 | -0.02 | 0.14 | 0.1 | 0.31 | 0.09 | 0.02 | -0.01 | 0.11 | 0.09 | 0.05 |
| Surprise Percentage | -5.7143% | 2.8571% | -2% | 15.2174% | 10.989% | 24.6032% | 8.5714% | 2.0408% | -1.0989% | 10.2804% | 10% | 5.7471% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-29 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 1.04 |
| Currency | USD |
Previous Dividend Records
| Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-08-14 | 2026-05-15 | 2026-02-13 | 2025-11-14 | 2025-08-15 | 2025-05-15 | 2025-02-14 | 2024-11-15 | 2024-08-15 | 2024-05-15 |
| Amount | $0.035 | $0.035 | $0.035 | $0.035 | $0.035 | $0.035 | $0.035 | $0.03 | $0.03 | $0.03 |
Next Dividend Records
| Dividend per share (year): | $0.14 |
| Dividend Yield | 0.21% |
| Next Dividend Date | 2026-08-14 |
| Ex-Dividend Date | 2026-07-24 |
Recent News: GEHC
2026-07-18 11:10:42
Desjardins has upgraded Vermilion Energy (NYSE:VET) to a "hold" rating, though the broader analyst consensus remains "Hold" with an average target price of $15.00. The stock recently opened at $9.82, trading within a 52-week range of $7.00 to $14.82, and reported a Q1 EPS loss of $0.67 on revenue of $369.04 million. Institutional investors have seen significant activity in the stock, with 31.91% of the shares owned by institutional investors and hedge funds.
2026-07-18 10:48:18
Wealthfront Advisers LLC increased its stake in Transdigm Group Incorporated ($TDG) by 12.8% during the first quarter, purchasing 881 additional shares and bringing its total holding to 7,750 shares valued at approximately $8.98 million. Other institutional investors also raised their positions, with 95.78% of Transdigm's stock now owned by institutional investors. Despite insider selling, the company's latest quarterly earnings exceeded expectations, and analysts currently have a consensus "Hold" rating with an average target price of $1,477.47.
2026-07-18 10:37:44
Wealthfront Advisers LLC significantly increased its stake in Fortinet (FTNT) by 16.4% during Q1, now holding 107,535 shares valued at $8.79 million. Fortinet reported strong Q1 results, surpassing EPS and revenue expectations. Despite a mixed analyst sentiment with a "Hold" consensus, several firms have raised price targets or upgraded the stock, while company insiders have recently sold shares.
2026-07-18 10:11:46
Future Fund LLC significantly increased its stake in Mercury Systems (NASDAQ:MRCY) by 66.1% in the first quarter, now owning 48,645 shares valued at $3.55 million. This increase follows strong quarterly results where Mercury Systems surpassed earnings per share and revenue estimates. Despite mixed analyst ratings, the stock carries a "Moderate Buy" consensus, though recent insider selling has also been noted.
2026-07-18 08:40:42
Sanctuary Advisors LLC significantly increased its stake in Unilever PLC (NYSE:UL) by 46.7% during the first quarter, now holding 170,240 shares valued at approximately $9.7 million. Other institutional investors also expanded their positions, leading to hedge funds and institutional investors collectively owning 9.67% of Unilever's stock. Despite the increased institutional interest, Unilever shares were down 0.6% to $62.35, with analysts maintaining a "Hold" consensus rating and a target price of $65.55.
2026-07-18 08:14:35
Bank of New York Mellon Corp significantly reduced its stake in MetLife, Inc. by 25.8% in the first quarter, selling over 1.2 million shares. Despite this, other institutional investors like Norges Bank and Vanguard Group Inc. increased their holdings. MetLife recently reported strong Q1 earnings, surpassing analyst expectations, and announced a quarterly dividend of $0.5925 per share.
